Booking.com has announced the recipients of its 13th annual Traveller Review Awards, revealing South Australia as one of the 'Top 10 Most Welcoming Regions on Earth'. Based on over 360 million ...

DeTect, Inc. (DeTect) is shipping a MERLIN True3D Bird Detection Radar (BDR) to Hanseo University's Flight Education Center ...

Increases in Australia's road toll over the past four years have been at a level not recorded since 1966, before the ...

EBC Financial Group (EBC), a leading global financial brokerage, proudly announces its latest Corporate Social Responsibility ...

Bybit, the world's second-largest crypto exchange by trading volume, is unleashing the rewarding power of its SOL liquid staking token bbSOL in the first mega airdrop of 2025, the bbSOL Golden Maxi ...

Despite the ongoing public debate kicked off by Coalition's plans for a nuclear-powered Australia if elected in 2025's general election, people working within the energy and resources sector are ...

Indie game developer Livia Games is excited to announce the relaunch of its popular immersive exercise app, Run the Realm, with a major update available on January 27th for Android and iOS devices.

Mediaocean, the foundational partner for omnichannel advertising, has been named top 10 overall, and top five in ad tech on the Ad Age Best Places to Work 2025. This prestigious ranking features the ...

The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. ...

Frost Sullivan recently researched the cloud consumer identity and access management (CIAM) industry and, based on its analysis, recognizes cidaas with the 2024 European Company of the Year award. The ...

EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold,” or the “Company”), a clean technology company that monetises mine waste and tailings while reducing environmental and ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug is mutation-agnostic, ...